🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
GeneReach Biotechnology Corp. (TPEX:4171)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
12.20
-1.10 (-8.27%)
Nov 20, 2026, 1:21 PM CST

GeneReach Biotechnology Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
241.13232.74206.49225.46750.021,012
Revenue Growth
11.99%12.71%-8.42%-69.94%-25.89%18.09%
Cost of Revenue
62.7671.8288.21197.88259.95265.1
Gross Profit
178.37160.93118.2827.58490.07746.98
Selling, General & Admin
168.22175.09173.63173.98191.05202.96
Research & Development
60.3672.7580.5161.4658.8156.61
Operating Expenses
223.11240.79249.49256.87248.73264.63
Operating Income
-44.74-79.86-131.22-229.29241.34482.35
Interest Expense
-4.73-6.51-5.93-5.76-6.61-6.26
Interest & Investment Income
5.529.031814.472.290.39
Currency Exchange Gain (Loss)
-21.52-21.5228.890.4529.39-11.55
Other Non Operating Income (Expenses)
49.83-4.331.453.572.983.32
EBT Excluding Unusual Items
-15.64-103.19-88.81-216.55269.38468.24
Gain (Loss) on Sale of Investments
-----0.04
Gain (Loss) on Sale of Assets
-0.5-0.5-0.57-1.391.70.41
Asset Writedown
-13-13-27.6---
Other Unusual Items
0.220.22--0.411.290.68
Pretax Income
-28.92-116.47-116.98-218.35272.37469.37
Income Tax Expense
-3.97-3.546.7-47.9954.8898.9
Earnings From Continuing Operations
-24.95-112.93-123.68-170.35217.49370.47
Minority Interest in Earnings
2.842.654.954.083.856.15
Net Income
-22.11-110.28-118.73-166.27221.34376.62
Net Income to Common
-22.11-110.28-118.73-166.27221.34376.62
Net Income Growth
-----41.23%46.38%
Shares Outstanding (Basic)
575757575757
Shares Outstanding (Diluted)
575757575959
Shares Change
-1.02%-0.79%--3.08%1.13%1.88%
EPS (Basic)
-0.39-1.93-2.07-2.893.856.55
EPS (Diluted)
-0.39-1.93-2.07-2.893.776.45
EPS Growth
-----41.59%44.19%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
6.34-19.87-30.35-62.21307.76329.43
Free Cash Flow Per Share
0.11-0.35-0.53-1.085.195.62
Dividend Per Share
----1.2003.636
Dividend Growth
-----67.00%45.43%
Gross Margin
73.97%69.14%57.28%12.23%65.34%73.81%
Operating Margin
-18.55%-34.31%-63.55%-101.70%32.18%47.66%
Profit Margin
-9.17%-47.38%-57.50%-73.75%29.51%37.21%
Free Cash Flow Margin
2.63%-8.54%-14.70%-27.59%41.03%32.55%
EBITDA
-2.45-22.24-69.95-174.3292.82531.28
EBITDA Margin
-1.02%-9.55%-33.88%-77.31%39.04%52.49%
D&A For EBITDA
42.2957.6261.2654.9851.4748.93
EBIT
-44.74-79.86-131.22-229.29241.34482.35
EBIT Margin
-18.55%-34.31%-63.55%-101.70%32.18%47.66%
Effective Tax Rate
----20.15%21.07%
Revenue as Reported
---225.46750.021,012